Charles River Laboratories Inte (CRL): Valuation
TTM figures as of June 27, 2026
Charles River Laboratories Inte trades at a 2.79% free-cash-flow yield. That FCF yield is higher than 14% of its own month-end history back to 2010.
Earnings yield -1.80%. Shareholder yield 2.44%. ROIC 2.7%. Net cash $176.7M.
195 month-end valuation observations are on file, starting June 2010.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is CRL cheap versus its own history?
Charles River Laboratories Inte trades at a 2.79% free-cash-flow yield. That FCF yield is higher than 14% of its own month-end history back to 2010.
What is CRL's free-cash-flow yield?
Charles River Laboratories Inte currently yields 2.79% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.